Skip to main content

US ClosedU.S. Closed

PLYX: Polaryx Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions.

52W Range

0thpctl

Volume

0.46×avg

Market Cap

102.68MUSD

P/E Ratio

-16.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Polaryx Therapeutics, Inc. Common Stock

PLYXNASDAQ Global Market·USD·Closed

Polaryx Therapeutics, Inc. Common Stock

PLYXNASDAQ·USD·Closed

$2.06

−2.37%

$2.06

−$0.05 (2.37%)

52W Range

0thpctl

Volume

0.46×avg

Mkt Cap

102.68MUSD

P/E

-16.9TTM

Div Yield

–ann